London Daily

Focus on the big picture.
Wednesday, Oct 22, 2025

Israel is offering a third Pfizer shot amid spiking cases, even as the U.S. says it's not yet needed

Israel is offering a third Pfizer shot amid spiking cases, even as the U.S. says it's not yet needed

Pfizer says its booster vaccine "has the potential to preserve the highest levels of protective efficacy against all currently known variants including Delta."

Israel will allow adults with severe pre-existing medical conditions to receive a third dose of the Pfizer vaccine against Covid-19, making it the first country in the world to do so.

The Israeli government’s decision comes as coronavirus infections rise due to the spread of the delta variant, but also stands in contrast to a recent statement from top U.S. health authorities regarding its own citizens that a booster shot isn’t actually needed.

Israel’s health ministry this week said that the booster will be offered to adults considered to be at risk, and specifically mentioned people with severe immunodeficiency or who have recently undergone an organ transplant.

It was not immediately clear whether the booster shot would also be made available to Palestinians living in Israeli-occupied territory.


Jury remains open


Covid cases in Israel jumped to more than 400 per day in early July after staying in the single digits for most of June — despite the fact that the country has been praised for executing one of the fastest vaccination campaigns in the world. More than 5 million of its 9 million citizens have been fully vaccinated against the disease.

But after fully reopening its economy in the spring, Israel has brought back some restrictions, including mandatory mask-wearing indoors and on public transport.

Still, despite the rise in case volume, Israel’s health ministry said during the first week of July that only 47 of the 4,000 registered active cases in the country were considered serious.

Meanwhile, the debate continues as to whether a third dose of any vaccine is necessary and will make a significant difference in protecting people from the virus. Health officials in the U.S. don’t take that to be the case so far.

“Americans who have been fully vaccinated do not need a booster shot at this time,” the U.S. Food and Drug Administration and Centers for Disease Control said in a joint statement on July 8.

“We continue to review any new data as it becomes available and will keep the public informed. We are prepared for booster doses if and when the science demonstrates that they are needed.”

In a press release issued on the same day, Pfizer and BioNTech said that a third dose of their vaccine “has the potential to preserve the highest levels of protective efficacy against all currently known variants including Delta.”

The American and German companies are currently developing a new version of their shot “that targets the full spike protein of the Delta variant,” the statement said.


‘A dangerous trend’


Pfizer has said it would request regulatory approval for its booster shot, while some countries where Chinese-made vaccines were widely administered are now offering a Pfizer booster amid doubts over the efficacy of Chinese vaccines. Bahrain and the United Arab Emirates are among the countries now offering a Pfizer booster for people who have received two doses of China’s Sinopharm, despite the jury remaining open as to whether the practice is ultimately safe.

On Monday, chief WHO scientist Soumya Swaminathan warned against mixing vaccines.

“It’s a little bit of a dangerous trend here … we’re in a data-free, evidence-free zone as far as mix and match (of vaccines),” she said during a press conference.

“There is limited data on mix and match, there are studies going on, we need to wait for that, maybe it will be a very good approach, but at the moment we only have data on the AstraZeneca followed by Pfizer. So, it will be a chaotic situation in countries if citizens start deciding when and who should be taking a third and fourth dose.”


Criticism over vaccine delivery to Palestinians


The West Bank’s ruling Palestinian Authority in June canceled a vaccine swap deal with Israel, under which it would have received 1 million doses of an ageing stock of Pfizer vaccines from Israel that needed to be used up, and would in exchange give Israel a similar number of Pfizer doses it planned to receive from the company later in the year.

But the stock’s expiry date was in June — the same month it was meant to be delivered to Israel — and the Palestinians rejected them, saying they were initially told the shots would expire in July and August. Israel denies this and says they were clear about the expiry dates.

Israel in January sent 5,000 vaccine doses to Palestinian health workers living in the West Bank, which rights activists and Palestinians say is insufficient and a dereliction of Israel’s duty of care as an occupying state.

Just over 30% of eligible Palestinians in the West Bank and Gaza have received at least one vaccine dose, Palestinian officials say, largely thanks to the COVAX vaccine sharing initiative and donations from various countries.

Comments

Oh ya 4 year ago
Go ahead if your over 18 to take as many of these DNA gene therapy shots as you want until it kills you. It is obvious you do not have at least 2 working brain cells. I see you daily driving around by yourself in the car with your mask on. Like someone once said.. Pity the fool

Newsletter

Related Articles

0:00
0:00
Close
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
Bessent Accuses China of Dragging Down Global Economy Amid New Trade Curbs
×